{"abstract": "Merck said the Food and Drug Administration had rejected an application for a new sleeping pill called suvorexant, but would probably approve it in smaller doses.", "web_url": "https://www.nytimes.com/2013/07/02/business/fda-prefers-smaller-dosage-of-merck-sleep-drug.html", "snippet": "Merck said the Food and Drug Administration had rejected an application for a new sleeping pill called suvorexant, but would probably approve it in smaller doses.", "lead_paragraph": "The Food and Drug Administration has rejected an application by Merck to sell a new sleeping pill, but indicated that it would probably approve the drug in lower doses.", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Prefers Smaller Dosage of Merck Sleep Drug", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 3, "major": "N"}, {"name": "subject", "value": "Sleep", "rank": 4, "major": "N"}], "pub_date": "2013-07-01T18:12:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/b039a449-57f1-5171-af3f-68c919668c99", "word_count": 313, "uri": "nyt://article/b039a449-57f1-5171-af3f-68c919668c99"}